Lilleta IUD abortifacient contraception levonorgestrel Medicines360 FDA

New abortifacient IUD Liletta approved by FDA

Posted on

Liletta (levonorgestrel) Intrauterine Device – formerly Levosert

Company: Medicines360 and Actavis plc
Date of Approval: February 27, 2015
Treatment for: Contraception [abortifacient mechanism of action, chemically and mechanically]

Liletta (levonorgestrel) is a hormonal intrauterine device (IUD) for use by women to prevent pregnancy for up to three years. The basic mechanism of action is abortifacient by action of the progestin levonorgestrel–which is poor at supressing ovulation–and the mechanical irritation of the endometrium after junior has been conceived and implanted in the womb.

Liletta FDA Approval History